Literature DB >> 10421803

Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma.

I Byrjalsen1, P Mose Larsen, S J Fey, L Nilas, M R Larsen, C Christiansen.   

Abstract

In the search for new markers of human endometrial hyperplasia and adenocarcinoma the method of quantitative two-dimensional gel electrophoresis was applied to study the protein expression profiles of metabolically [(35)S]-methionine-labelled proteins of endometrial explants. Approximately 1700 protein spots were resolved by the two-dimensional gel electrophoresis, and the expression pattern of each of these proteins was assessed for increased expression during hyperplasia or adenocarcinoma. In total, six protein spots showed increased expression in hyperplasia, 19 in carcinoma, and eight in both hyperplasia and carcinoma. Twelve of these 33 differentially expressed proteins were identified by peptide mass mapping combined with sequence database searching. Among the identified proteins were proteins involved in cellular transport and chaperoning, i.e. heat shock protein 27 kDa protein, heat shock 70 kDa protein, heat shock cognate 71 kDa protein, and serotransferrin. Other identified proteins were: regulatory chain protein of cAMP-dependent protein kinase, prohibitin, and heterogeneous nuclear ribonucleoprotein A2/B1. Finally we identified proteins associated with the cytoskeleton, vimentin and tropomyosin isoform 3, and the glycolytic pathway, alpha enolase, and phosphoglycerate kinase. The remaining unidentified proteins were either not contained in the database and must be assumed to be novel proteins, or were present in too low amounts to allow characterization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421803     DOI: 10.1093/molehr/5.8.748

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

1.  Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.

Authors:  G Larry Maxwell; Brian L Hood; Roger Day; Uma Chandran; David Kirchner; V S Kumar Kolli; Nicolas W Bateman; Jay Allard; Caela Miller; Mai Sun; Melanie S Flint; Chris Zahn; Julie Oliver; Subhadra Banerjee; Tracy Litzi; Anil Parwani; Glenn Sandburg; Scott Rose; Michael J Becich; Andrew Berchuck; Elise Kohn; John I Risinger; Thomas P Conrads
Journal:  Gynecol Oncol       Date:  2011-04-01       Impact factor: 5.482

2.  Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells.

Authors:  Nish Patel; Sabarni K Chatterjee; Vladimir Vrbanac; Ivy Chung; Chunyao Jenny Mu; Rachelle R Olsen; Carol Waghorne; Bruce R Zetter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

3.  The role of phenotypic plasticity on the proteome differences between two sympatric marine snail ecotypes adapted to distinct micro-habitats.

Authors:  Mónica Martínez-Fernández; María Páez de la Cadena; Emilio Rolán-Alvarez
Journal:  BMC Evol Biol       Date:  2010-03-08       Impact factor: 3.260

4.  Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.

Authors:  Yi-sheng Wang; Rui Cao; Hong Jin; Yi-ping Huang; Xiao-yan Zhang; Qing Cong; Yi-feng He; Cong-jian Xu
Journal:  J Hematol Oncol       Date:  2011-04-14       Impact factor: 17.388

5.  Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.

Authors:  Khalid Akkour; Ibrahim O Alanazi; Assim A Alfadda; Hani Alhalal; Afshan Masood; Mohthash Musambil; Anas M Abdel Rahman; Moudi A Alwehaibi; Maria Arafah; Ali Bassi; Hicham Benabdelkamel
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

Review 6.  Mitochondrial dysfunction in cancer.

Authors:  Kinga Księżakowska-Łakoma; Monika Żyła; Jacek R Wilczyński
Journal:  Prz Menopauzalny       Date:  2014-05-21

Review 7.  Proteomic Biomarkers for the Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.